Diseases, Conditions, Syndromes

Researchers use stem cells to combat COVID-19 pneumonia

When news of the coronavirus emerged from Wuhan, China, Kunlin Jin, Ph.D., and a team of international researchers quickly joined forces to fight the mysterious disease.

Cardiology

Evinacumab cuts cholesterol levels by half in patients with HoFH

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled ...

Genetics

Benefiting from the national gene vector biorepository

Gene therapy investigators can greatly benefit from the resources and services provided by the National Gene Vector Biorepository (NGVB), housed at the Indiana University School of Medicine. These include 93 unique reagents, ...

Diseases, Conditions, Syndromes

Forgotten tale of phage therapy history revealed

In the current situation when the fear of virus infections in the public is common, it is good to remember that some viruses can be extremely beneficial for mankind, and even save lives. Such viruses—phages—infect bacteria. ...

Oncology & Cancer

Lung cancer therapy may improve outcomes of metastatic brain cancer

A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St. Michael's ...

Oncology & Cancer

10-year outcomes similar for H-IMRT, C-IMRT in prostate cancer

(HealthDay)—For men with intermediate- and high-risk prostate adenocarcinoma, 10-year outcomes are similar with conventionally fractionated intensity-modulated radiation therapy (C-IMRT) or moderate hypofractionated IMRT ...

page 2 from 100